Literature DB >> 7883988

Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

E B Lankford1, N D Epstein, L Fananapazir, H L Sweeney.   

Abstract

Missense mutations in the beta-myosin heavy chain (beta-MHC) gene cause hypertrophic cardiomyopathy (HCM). As normal and mutant beta-MHCs are expressed in slow-twitch skeletal muscle of HCM patients, we compared the contractile properties of single slow-twitch muscle fibers from patients with three distinct beta-MHC gene mutations and normal controls. Fibers with the 741Gly-->Arg mutation (near the binding site of essential light chain) demonstrated decreased maximum velocity of shortening (39% of normal) and decreased isometric force generation (42% of normal). Fibers with the 403Arg-->Gln mutation (at the actin interface of myosin) showed lowered force/stiffness ratio (56% of normal) and depressed velocity of shortening (50% of normal). Both the 741Gly-->Arg and 403Arg-->Gln mutation-containing fibers displayed abnormal force-velocity relationships and reduced power output. Fibers with the 256Gly-->Glu mutation (end of ATP-binding pocket) had contractile properties that were indistinguishable from normal. Thus there is variability in the nature and extent of functional impairments in skeletal fibers containing different beta-MHC gene mutations, which may correlate with the severity and penetrance of the disease that results from each mutation. These functional alterations likely constitute the primary stimulus for the cardiac hypertrophy that is characteristic of this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883988      PMCID: PMC441484          DOI: 10.1172/JCI117795

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Hypertrophic cardiomyopathy: a discussion of nomenclature.

Authors:  B J Maron; S E Epstein
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

2.  Skeletal muscle myosin light chains are essential for physiological speeds of shortening.

Authors:  S Lowey; G S Waller; K M Trybus
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

3.  A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.

Authors:  L Thierfelder; C MacRae; H Watkins; J Tomfohrde; M Williams; W McKenna; K Bohm; G Noeske; M Schlepper; A Bowcock
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Chemically skinned mammalian skeletal muscle. I. The structure of skinned rabbit psoas.

Authors:  A B Eastwood; D S Wood; K L Bock; M M Sorenson
Journal:  Tissue Cell       Date:  1979       Impact factor: 2.466

5.  Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.

Authors:  V Dilsizian; R O Bonow; S E Epstein; L Fananapazir
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

6.  Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11.

Authors:  L Carrier; C Hengstenberg; J S Beckmann; P Guicheney; C Dufour; J Bercovici; E Dausse; I Berebbi-Bertrand; C Wisnewsky; D Pulvenis
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

7.  Three-dimensional structure of myosin subfragment-1: a molecular motor.

Authors:  I Rayment; W R Rypniewski; K Schmidt-Bäse; R Smith; D R Tomchick; M M Benning; D A Winkelmann; G Wesenberg; H M Holden
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

8.  Structure of the actin-myosin complex and its implications for muscle contraction.

Authors:  I Rayment; H M Holden; M Whittaker; C B Yohn; M Lorenz; K C Holmes; R A Milligan
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

9.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Authors:  R Anan; G Greve; L Thierfelder; H Watkins; W J McKenna; S Solomon; C Vecchio; H Shono; S Nakao; H Tanaka
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

Authors:  L Fananapazir; N D Epstein
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

View more
  50 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Aging-related changes in skeletal muscle. Mechanisms and interventions.

Authors:  L Larsson; B Ramamurthy
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

Review 3.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

4.  Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes.

Authors:  Gaynor Miller; Joanne Maycock; Ed White; Michelle Peckham; Sarah Calaghan
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

5.  Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.

Authors:  Mirco Müller; Antonina Joanna Mazur; Elmar Behrmann; Ralph P Diensthuber; Michael B Radke; Zheng Qu; Christoph Littwitz; Stefan Raunser; Cora-Ann Schoenenberger; Dietmar J Manstein; Hans Georg Mannherz
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

Review 6.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

7.  Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy.

Authors:  C H Thompson; G J Kemp; D J Taylor; M Conway; B Rajagopalan; A O'Donoghue; P Styles; W J McKenna; G K Radda
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

Review 8.  New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies.

Authors:  G A MacGowan; D M McNamara
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

9.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.

Authors:  O Roopnarine; L A Leinwand
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

10.  Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function.

Authors:  H L Sweeney; H S Feng; Z Yang; H Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.